Prescribing differences in family practice for diabetic patients in Germany according to statutory or private health insurance: the case of DPP-4-inhibitors and GLP-1-agonists
Crossref DOI link: https://doi.org/10.1186/s12875-016-0543-7
Published Online: 2016-10-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laux, Gunter
Berger, Sarah
Szecsenyi, Joachim
Kaufmann-Kolle, Petra
Leutgeb, RĂ¼diger